Health & biology · 2017

CAR-T cell therapy

Patients' own T cells, engineered with an antibody-like receptor, hunt down leukaemia.

Kymriah became the first approved CAR-T therapy in August 2017, for children with relapsed leukaemia. Many patients with no other options reached lasting remissions.

See it in the living tree Wikipedia

Arcs above join it to what it stood on, arcs below to what it led to. The bar places this stretch on the tree's whole timeline.

What it built on 2

Gene therapy 1990
Monoclonal antibodies 1974

Related measurements

The dashed line marks when it first worked.

Life expectancy in the UK since 1543 Latest: 81.3 years (2023) Source: Our World in Data